16 results
8-K
EX-10.1
ARCT
Arcturus Therapeutics Holdings Inc
4 Nov 22
Entry into a Material Definitive Agreement
5:00pm
, customer lists, supplier lists, trade secrets, designs, product formulations, product specifications, systems, know-how or any other proprietary
8-K
EX-14.1
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
if you:
Cause Arcturus to engage in business transactions with relatives or friends;
Use information of Arcturus, a customer or supplier for your own … . Specifically, with respect to any supplier, contract manufacturing organization, contract research organization, subcontractor, customer, competitor, funding
8-K
EX-1.1
le446iremo7czq
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
elsyfdx4y j98z
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
1hrkdl n61xn05n0
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
10-K
7hqeb
16 Mar 20
Annual report
11:09am
8-K12B
EX-14.1
hc9yf8
14 Jun 19
Notification of registration of securities
5:10pm
424B3
4gkziw1
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
psmcb8 gdgvv7
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
27j82uj 2sj4xaboywte
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next